BIOMAT Database Logo BIOMAT Database Logo

Androgen metabolism by human prostatic tumours in organ culture. 1983

C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian

Metabolism of testosterone and 5 alpha-dihydrotestosterone were investigated in benign and malignant human prostatic tumours maintained for 48 hr in organ culture. When tritiated testosterone was used as substrate there were significant differences between the metabolic pathways of the two types of tumour. Whilst the benign tumour had a predominantly reductive pathway leading to the formation of 5 alpha-reduced metabolites of testosterone, an oxidative pathway producing androstenedione was found to be the major pathway operative in the intermediate and poorly differentiated malignant specimens studied. In contrast to these differences observed in the metabolic pathway of testosterone when tritiated 5 alpha-dihydrotestosterone was used as substrate, no significant differences in the pattern of radiometabolites were observed.

UI MeSH Term Description Entries
D008297 Male Males
D009252 NADPH Dehydrogenase A flavoprotein that reversibly oxidizes NADPH to NADP and a reduced acceptor. EC 1.6.99.1. NADP Dehydrogenase,NADP Diaphorase,NADPH Diaphorase,Old Yellow Enzyme,TPN Diaphorase,Dehydrogenase, NADP,Dehydrogenase, NADPH,Diaphorase, NADP,Diaphorase, NADPH,Diaphorase, TPN,Enzyme, Old Yellow
D009924 Organ Culture Techniques A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1) Organ Culture,Culture Technique, Organ,Culture Techniques, Organ,Organ Culture Technique,Organ Cultures
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000735 Androstenedione A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. 4-Androstene-3,17-dione,delta-4-Androstenedione,4 Androstene 3,17 dione,delta 4 Androstenedione
D013196 Dihydrotestosterone A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. 5 alpha-Dihydrotestosterone,Androstanolone,Stanolone,17 beta-Hydroxy-5 beta-Androstan-3-One,17beta-Hydroxy-5alpha-Androstan-3-One,5 beta-Dihydrotestosterone,5-alpha Dihydrotestosterone,5-alpha-DHT,Anaprotin,Andractim,Dihydroepitestosterone,Gelovit,17 beta Hydroxy 5 beta Androstan 3 One,17beta Hydroxy 5alpha Androstan 3 One,5 alpha DHT,5 alpha Dihydrotestosterone,5 beta Dihydrotestosterone,Dihydrotestosterone, 5-alpha,beta-Hydroxy-5 beta-Androstan-3-One, 17
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone

Related Publications

C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
Androgen metabolism in human prostatic tissue.
January 1972, Endocrinologia experimentalis,
C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
Following human tumours in primary organ culture.
January 1967, Neoplasma,
C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
Organ culture studies of human prostatic adenocarcinomas.
January 1983, The Prostate,
C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
Metabolism and action of steroid hormones on human benign prostatic hyperplasia and prostatic carcinoma grown in organ culture.
July 1979, Journal of steroid biochemistry,
C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
The metabolism of testosterone by human prostate in organ culture.
September 1970, The Journal of endocrinology,
C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
[Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)].
January 1993, Verhandlungen der Deutschen Gesellschaft fur Pathologie,
C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
Androgen metabolism in the human prostatic cancer cell line LNCaP.
October 1994, The Journal of steroid biochemistry and molecular biology,
C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
Androgen metabolism in cultured prostatic cells.
January 1984, Progress in clinical and biological research,
C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
Metabolism of I-131 by human thyroid tissue in organ culture.
May 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
C B Smith, and J R Masters, and S A Metcalfe, and R Ghanadian
Doxapram metabolism in human fetal hepatic organ culture.
July 1991, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!